Overview


According to FutureWise analysis the market for europe bioinformatics in 2023 is US$ 3.33 billion, and is expected to reach US$ 9.86 billion by 2031 at a CAGR of 14.52%.

The rising requirement of bioinformatics in clinical diagnostics and manufacturing newer medicines, increasing need for protein and nuclei acid sequencing, growing need for integrated bioinformatics systems in the fields of genomics and proteomics and the increased governmental initiatives are some of the factors responsible for the growth of the Europe bioinformatics market. High costs, lack of skilled labor are some of the constraints of the market growth.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Europe Bioinformatics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Europe Bioinformatics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • AGILENT TECHNOLOGIES
  • AFFYMETRIX INC.
  • APPLIED BIOLOGICAL MATERIALS
  • 3RD MILLENIUM INC.
  • ILLUMINA INC.
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN N.V
  • BIOMAX INFORMATICS AG
  • DNA NEXUS INC.
  • VICTUS INC.
  • WATERS CORP.

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Sector

  • Animal Biotechnology
  • Environmental Biotechnology
    • Alternative Energy Sources
    • Waste Clean-Up/ Bioremediation
    • Climate Change Studies
  • Agricultural Biotechnology
    • Crop Yield Improvement
    • Post Resistance
    • Improvement of Plant Resistance
    • Biodiversity Informatics
    • Nutritional Quality Improvement
  • Forensic Biotechnology
  • Medical Biotechnology
    • Drug Development
    • Clinical Diagnostics
    • Molecular Medicine
      • Personalized Medicine
      • Preventive Medicine
    • Gene Therapy

By Products and Services

  • Bioinformatics Platforms
    • Sequence Analysis Platforms
    • Sequence Alignment Platforms
    • Sequence Manipulation Platforms
    • Structural and Functional Analysis Platforms
  • Knowledge Management Tools
    • Generalized Knowledge Management Tools
    • Specialized Knowledge Management Tools
  • Bioinformatics Services
    • Data Analysis
    • Sequencing Services
    • Database and Management Services

By Application

  • Proteomics
  • Transcriptomics
  • Molecular Phylogenetics
  • Chemo informatics
  • Drug Design and Genomics

By Region

  • Germany
  • U.K
  • France
  • Italy
  • Spain
  • Russia
  • Poland
  • Switzerland
  • Romania
  • Rest of Western Europe.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Europe Bioinformatics Market By Sector, By Products and Services, By Application, and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— Germany, U.K, France, Italy, Spain, Russia, Poland, Switzerland, Romania, Rest of Western Europe.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data From Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Europe Bioinformatics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards And Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Biotech Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Europe Bioinformatics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Europe Bioinformatics Market , By Sector Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Animal Biotechnology
        2. Environmental Biotechnology
         2.1. Alternative Energy Sources
         2.2. Waste Clean-Up/ Bioremediation
         2.3. Climate Change Studies
        3. Agricultural Biotechnology
         3.1. Crop Yield Improvement
         3.2. Post Resistance
         3.3. Improvement of Plant Resistance
         3.4. Biodiversity Informatics
         3.5. Nutritional Quality Improvement
        4. Forensic Biotechnology
        5. Medical Biotechnology
         5.1. Drug Development
         5.2. Clinical Diagnostics
         5.3. Molecular Medicine
          5.3.1. Personalized Medicine
          5.3.2. Preventive Medicine
         5.4. Gene Therapy

  • 8.   Europe Bioinformatics Market, By Products and Services and Services Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bioinformatics Platforms
         1.1. Sequence Analysis Platforms
         1.2. Sequence Alignment Platforms
         1.3. Sequence Manipulation Platforms
         1.4. Structural and Functional Analysis Platforms
        2. Knowledge Management Tools
         2.1. Generalized Knowledge Management Tools
         2.2. Specialized Knowledge Management Tools
        3. Bioinformatics Services
         3.1. Data Analysis
         3.2. Sequencing Services
         3.3. Database and Management Services

  • 9.   Europe Bioinformatics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Proteomics
        2. Transcriptomics
        3. Molecular Phylogenetics
        4. Chemo informatics
        5. Drug Design and Genomics

  • 10.   Europe Bioinformatics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Switzerland
         2.9. Romania
         2.10. Rest of Western Europe
             3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 11.  Market Share Analysis and Competitive Landscape
    •   1. Europe Landscape - Key Players, Revenue and Presence
        2. Europe Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Europe Emerging Companies
        4. Europe - Market Share Analysis and Key Regional Players
        5. Europe Key Player - Growth Matrix

  • 12.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •  1. AGILENT TECHNOLOGIES
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. AFFYMETRIX INC.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. APPLIED BIOLOGICAL MATERIALS
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. 3RD MILLENIUM INC.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. ILLUMINA INC.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. THERMO FISHER SCIENTIFIC INC.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. QIAGEN N.V
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. BIOMAX INFORMATICS AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. DNA NEXUS INC.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
          10. WATERS CORP.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 13.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated
      by administrations
        5. The overall economic slowdown of the developing and developed nations

  • 14.  FutureWise SME Key Takeaway Points for Client
    •    

Partner

Our Clients